Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2880002 | 0.85 | ALDH1A1 (0.62) | ALDH1A1TSHRHPGDHTTHSD17B10 | |
| SCHEMBL3202573 | 0.84 | ALDH1A1 (0.72) | ALDH1A1TSHRHPGDHTTHSD17B10 | |
| SCHEMBL301933 | 0.82 | ALDH1A1 (0.69) | ALDH1A1TSHRHPGDHTTHSD17B10 | |
| SCHEMBL14363082 | 0.80 | TDP1 (0.64) | ALDH1A1TSHRHPGDHSD17B10L3MBTL1 | |
| Ammonia Solution, Strong SCHEMBL10338964 | 0.80 | ALDH1A1 (0.67) | ALDH1A1TSHRHPGDHTTHSD17B10 | |
| SCHEMBL29437308 | 0.80 | ALDH1A1 (0.67) | ALDH1A1TSHRHPGDHTTHSD17B10 | |
| SCHEMBL1150551 | 0.80 | ALDH1A1 (0.67) | ALDH1A1TSHRHPGDHTTHSD17B10 | |
| SCHEMBL124981 | 0.80 | ALDH1A1 (0.67) | ALDH1A1TSHRHPGDHTTHSD17B10 | |
| SCHEMBL8867793 | 0.79 | ALDH1A1 (0.60) | ALDH1A1TSHRHPGDHTTHSD17B10 | |
| SCHEMBL3937020 | 0.79 | ALDH1A1 (0.55) | ALDH1A1TSHRHPGDHTTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119613769-A | Photo-crosslinked hydrogel, preparation method and application thereof, radionuclide preparation and application | 上海交通大学 | 2025-03-14 | — | — | CN | claimed |
| US-12247089-B2 | Photo-coupled synergistically crosslinked hydrogel material and its composition, preparation method, use, product, and preparation kit | Zhongshan Guanghe Medical Technology Co., Ltd. (CN) | 2025-03-11 | — | — | US | claimed |
| CN-117801754-A | Water-based adhesive, preparation method thereof and electrode plate | 广州鹿山新材料股份有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-116377720-B | Thermochromic waterproof fabric and preparation method thereof | 江苏瑞洋安泰新材料科技有限公司 | 2023-10-17 | — | — | CN | claimed |
| CN-114806275-B | Printing ink, display panel and preparation method thereof | 深圳市华星光电半导体显示技术有限公司 | 2023-05-30 | — | — | CN | claimed |
| CN-114806275-A | Printing ink, display panel and preparation method thereof | 深圳市华星光电半导体显示技术有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-112062699-B | Preparation method of o-aminothiophenol | 苏州开元民生科技股份有限公司 | 2021-02-26 | — | — | CN | claimed |
| CN-112266367-A | Preparation, raw material, product and application of photo-crosslinking hydrogel material | 中山光禾医疗科技有限公司 | 2021-01-26 | — | — | CN | claimed |
| CN-112062699-A | Preparation method of o-aminothiophenol | 苏州开元民生科技股份有限公司 | 2020-12-11 | — | — | CN | claimed |
| CN-109776451-B | Preparation, raw material, product and application of photo-crosslinking hydrogel material | 中山光禾医疗科技有限公司 | 2020-12-11 | — | — | CN | claimed |
| US-20200262939-A1 | PHOTO-COUPLED SYNERGISTICALLY CROSSLINKED HYDROGEL MATERIAL AND ITS COMPOSITION, PREPARATION METHOD, USE, PRODUCT, AND PREPARATION KIT | Zhongshan Guanghe Medical Technology Co., Ltd. (CN) | 2020-08-20 | — | — | US | claimed |
| CN-119613769-B | Photo-crosslinked hydrogel, preparation method and application thereof, radionuclide preparation and application | 上海交通大学 | 2025-10-17 | — | — | CN | disclosed |
| CN-119613769-A | Photo-crosslinked hydrogel, preparation method and application thereof, radionuclide preparation and application | 上海交通大学 | 2025-03-14 | — | — | CN | disclosed |
| CN-119613769-A | Photo-crosslinked hydrogel, preparation method and application thereof, radionuclide preparation and application | 上海交通大学 | 2025-03-14 | — | — | CN | disclosed |
| US-12247089-B2 | Photo-coupled synergistically crosslinked hydrogel material and its composition, preparation method, use, product, and preparation kit | Zhongshan Guanghe Medical Technology Co., Ltd. (CN) | 2025-03-11 | — | — | US | disclosed |
| EP-0017992-A1 | 2-Substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids, processes for preparing them, antibiotic pharmaceutical compositions containing same and process for preparing intermediates | MERCK & CO. INC. (US) | 1980-10-29 | — | — | EP | disclosed |
| US-4218463-A | ANTIBIOTICS | MERCK & CO., INC. (US) | 1980-08-19 | — | — | US | disclosed |
| EP-0010317-A1 | 6-, 1- and 2-substituted-1-carbapen-2-em-3-carboxylic acids, processes for the preparation of such compounds and pharmaceutical composition comprising such compounds | MERCK & CO. INC. (US) | 1980-04-30 | — | — | EP | disclosed |
| EP-0001628-A1 | 3-Substituted-6-substituted-7-oxo-1-azabicyclo (3.2.0)-hept-2-ene-2-carboxylic acid, its preparation and pharmaceutical compositions containing it | MERCK & CO. INC. (US) | 1979-05-02 | — | — | EP | disclosed |
| EP-0001627-A1 | 3-Substituted-6-(1'hydroxethyl)-7-oxo-1-azabicyclo(3.2.0.)-hept-2-ene-2-carboxylic acid, its preparation and pharmaceutical compositions containing it | MERCK & CO. INC. (US) | 1979-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12247089-B2 | Photo-coupled synergistically crosslinked hydrogel material and its composition, preparation method, use, product, and preparation kit | PKN3, JAK3, KIT | ALDH1A1 92/4885TSHR 3722/4885HPGD 227/4885 |
| US-20200262939-A1 | PHOTO-COUPLED SYNERGISTICALLY CROSSLINKED HYDROGEL MATERIAL AND ITS COMPOSITION, PREPARATION METHOD, USE, PRODUCT, AND PREPARATION KIT | PKN3, JAK3, KIT | ALDH1A1 92/4885TSHR 3722/4885HPGD 227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.